PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms
Open Access
- 1 January 2014
- journal article
- review article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 4 (4) , 336-365
Abstract
Gastroenteropancreatic neuroendocrine neoplasms are heterogeneous in their clinical behavior and require therapies specially tailored according to staging, grading, origin and expression of peptide receptors. Despite extensive scientific efforts, the therapy options are still not satisfactory. The main reasons are due to the lack of a broad mechanistic knowledge, an insufficient classification of specific diagnostic sub-groups, and predictive markers. GEP-NEN tumors evade early diagnosis because of slow asymptomatic growth behavior and are frequently not detected until metastasized. How signaling networks contribute to tumor progression and how these networks interact remains unclear in large parts. In this review we summarize the knowledge on the growth factor responsive non-angiogenetic pathways in sporadic GEP-NENs, highlight promising mechanistic research approaches, and describe important therapy targets.Keywords
This publication has 543 references indexed in Scilit:
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- PTEN: a tumour suppressor that functions as a phospholipid phosphataseTrends in Cell Biology, 1999
- Protein Tyrosine Phosphatase-η Expression Is Upregulated by the PKA-Dependent and Is Downregulated by the PKC-Dependent Pathways in Thyroid CellsExperimental Cell Research, 1998
- Induction of Apoptosis in Neuroendocrine Tumors of the Digestive System During Treatment with Somatostatin AnalogsActa Oncologica, 1997
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Tautomycin: An inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomachJournal of Cancer Research and Clinical Oncology, 1995
- The activation of phosphatidylinositol 3-kinase by RasCurrent Biology, 1994
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- SomatostatinNew England Journal of Medicine, 1983